Find Academic Supervisors

• Quantum Computing Optimization
• Interior Point Methods
• Semidefinite Optimization
• +11 more

Professor Tamás Terlaky holds the Alcoa Endowed Chair at Lehigh University 's P.C. Rossin College of Engineering and Applied Science , directing the Quantum Computing and Optimization Laboratory (QCOL) . He maintains Adjunct Professor roles at McMaster University and University of Pannonia , and serves as Visiting Professor at Strathclyde University . Ph.D. & M.Sc. from Eötvös University, Budapest Doctor of Academy of Sciences (Hungary) Habilitation from University of Pannonia Research Interests span Quantum Computing Optimization , Interior Point Methods , High-Performance Computational Optimization , Mathematical Modeling , and Medical Engineering Applications . Specific foci include Proton Therapy Treatment Optimization , Nuclear Reactor Core Reloading , and Service System Optimization . Recent Publications demonstrate expertise in Quantum Interior Point Methods , Quantum Linear System Algorithms , and Combinatorial Optimization , with applications to Medical Physics , Structural Engineering , and Quantum Software Design . Scientific Awards : Fellow of Fields Institute , INFORMS , SIAM , IFORS , and Canadian Academy of Engineering INFORMS Wagner Prize recipient IISE Outstanding Innovation in Service Science award MITACS Mentorship Award Teaching includes courses on Conic Optimization , Interior Point Methods , and Optimization Methods and Software . Currently leading a $2.1M DARPA grant for Quantum Computing Optimization research.

Gustavo MachadoView profile

Associate Professor

• Back pain
• Musculoskeletal pain
• Physiotherapy
• +5 more

Associate Professor Gustavo Machado is an NHMRC Investigator (EL2) and Robinson Fellow at the Institute for Musculoskeletal Health, Sydney Local Health District and the School of Public Health, University of Sydney. He serves on the Board of the Faculty of Medicine and Health, is a core member of the Emergency Care Institute Research Advisory Committee, and chairs multiple research steering committees including SMART-ED, BACK@HOME, and RESHAP-ED trials. His work spans clinical research, health services innovation, and implementation science with direct impact on emergency department care for musculoskeletal conditions. Dr. Machado completed his PhD in Medicine at the University of Sydney in 2017. His academic trajectory has been marked by significant research funding success including an NHMRC Early Career Fellowship (2017) and NHMRC Investigator Grant (2023), along with the prestigious Robinson Fellowship from the University of Sydney. Associate Professor Machado's research program focuses on transforming the care of people with musculoskeletal pain in emergency and pre-hospital settings. His work investigates effectiveness of interventions including medicines, physiotherapy, exercise therapy, and innovative care models through large-scale clinical trials, observational studies, and systematic reviews. With over 100 peer-reviewed publications in top journals including BMJ, Lancet Rheumatology, and Cochrane, his research has been cited over 5,500 times (h-index=32) and has changed clinical practice guidelines including NICE recommendations. He has developed hospital-based business intelligence platforms linking administrative health datasets, which won the NPS Medicinewise Award for Excellence in eHealth Resources. His publication portfolio demonstrates a clear evolution from foundational clinical epidemiology research toward implementation science and health services innovation, with increasing emphasis on reducing low-value care such as inappropriate opioid prescribing for back pain. His recent work focuses on virtual hospital models, primary-contact physiotherapy services, and data-driven quality improvement initiatives. Major Scientific Recognition: 2025 FMH Makers and Shapers Award for Outstanding Research - Teams 2024 EMCR Outstanding Publication Award for Lancet Rheum 2023,5:E643-E645 2023 NHMRC Investigator Grant (EL2) and Robinson Fellowship 2022 ANZMUSC Clinical Trial of the Year Award 2019 NSW Health Secretary's Award in Value Based Health Care 2018 NPS Medicinewise Award for Excellence in eHealth Resources 2017 NHMRC Early Career Fellowship Associate Professor Machado has supervised or mentored 16 research students and postdocs, with all former students securing prestigious academic positions. His students have received scholarships, best presentation awards, and best publication awards. He received the Dean's Citation Award for Learning & Teaching and was nominated for the SUPRA Supervisor of the Year Award and Good Mentor Award in 2023-24. His research has secured over $25.5 million in funding over the past 8 years from sources including NHMRC ($4.8M for SMART-ED) and MRFF ($3.2M for ADAPT-ED, $2.8M for RESHAP-ED). He leads six major research initiatives addressing critical challenges in emergency department management of musculoskeletal pain. He chairs the Digital and Virtual Care committee at Sydney Musculoskeletal Health and serves on multiple national research networks including the Australia & New Zealand Musculoskeletal Clinical Trials Network and Australasian College for Emergency Medicine Clinical Trials Network. His collaborative work spans international partnerships with institutions in Denmark, Netherlands, Norway, UK, and the United States.

Moniek de MaatView profile

Professor

• Biochemistry of Haemostasis
• Thrombosis
• Fibrinogen Variants
• +7 more

Prof. Moniek de Maat is a leading researcher in the Biochemistry of Haemostasis and Thrombosis at the Erasmus University Medical Center (Rotterdam, Netherlands) and a Visiting Professor at the University Hospital of South West Denmark. Her work focuses on fibrinogen variants , fibrin network architecture , and their roles in thrombosis , stroke outcomes , and coagulation disorders . Education: PhD in Biochemistry (1995, Erasmus University), Chemistry (Biochemistry) at Utrecht University (1987-1991). Career: Senior researcher at TNO (1991-1999, 1999-2003), Associate Professor (2003-2018), and Professor (2018-present) at Erasmus MC, Head of Hemostasis Lab (2008-2023). Research Focus: Her work explores how genetic and protein variation in fibrinogen affects clot stability , fibrinolysis , and thrombosis risk . She investigates biomarkers for acute ischemic stroke and NETosis (neutrophil extracellular traps) in cardiovascular and infectious diseases like COVID-19 . Her team studies fibrin network properties under flow and in biofilms , aiming to optimize patient treatment. Publication Trends: Recent articles (2023-2025) highlight her expertise in fibrinogen variants , NETs , and stroke biomarkers , with collaborations in diabetes , COVID-19 coagulopathy , and biofilm-related thrombosis . Key journals include J Thromb Haemost , Acta Biomater , and TH Open . Scientific Awards: Outstanding Investigator Award, International Fibrinogen Research Society (2010) Advising: She mentors PhD students (Aarazo Barakzie, Hande Eyisoylu) and postdocs (Charlene Jacqmarcq), with alumni (Tirsa Koopman). Her lab collaborates with departments in epidemiology , cardiology , pediatric hematology , microbiology , and neurology across institutions like TU Delft and MUMC+ .

• Ethics of technology
• Political ethics
• AI ethics
• +5 more

Matthias Braun is Professor of Social Ethics at the Faculty of Protestant Theology at the University of Bonn, holding the Chair of (Social) Ethics since the winter semester of 2022/23. Previously, he was head of the junior research group "Ethics and Governance of New Technologies" at the Friedrich-Alexander University Erlangen-Nuremberg until 2022. His academic journey includes research positions at institutions in Marburg, Erlangen, Bergen, Maastricht, and Oxford. Braun's research focuses on the ethical and governance challenges of emerging technologies, particularly examining how new technologies change social forms of life and institutions. His work spans political ethics, AI ethics, digital twin technology, data governance, and theological ethics. Using empirical and analytical-hermeneutic methods, he assesses social values and norms to develop responsible approaches to technological development. His recent publications demonstrate a clear trajectory toward increasingly sophisticated examinations of technology's societal impacts, with a growing emphasis on practical implementation of ethical frameworks. The research shows deep engagement with both theoretical foundations and concrete applications, particularly in healthcare contexts where ethical considerations have immediate real-world consequences. European Research Council research award recipient Falling Walls Award in Social Science and Humanities Braun leads the ERC-funded project on the ethics of digital twins and collaborates extensively across disciplinary boundaries. His work with the Collaborative Research Center EmpkinS and the Transdisciplinary Research Center "Life & Health" demonstrates his commitment to bridging academic research with practical societal concerns. Through initiatives like the Lunch Series on "Ethics, AI, and Health" and the "SciCom with Kids" program, he actively engages with diverse audiences to foster public discourse on technology ethics.

Dinesh Acharya UView profile

Professor

• Machine Learning
• Data Mining
• Image Processing
• +4 more

Dinesh Acharya U serves as a Professor in the Department of Computer Science and Engineering at Manipal Institute of Technology, Manipal University. His academic leadership spans both foundational computer engineering and interdisciplinary medical applications, with research output consistently growing since 2006. Current affiliations include active roles at the School of Computer Engineering with verified ORCID profile (0000-0002-0304-4725) and institutional webpage. Research interests prominently feature Machine Learning (68% fingerprint weight), Data Mining (40%), and Medical Informatics applications. His work bridges computer science with healthcare challenges, particularly in neonatal sepsis detection, diabetic complications, and low-resource language processing. The research fingerprint shows strong emphasis on prediction (52%), algorithms (53%), and India -specific healthcare contexts (40%). Publication trends reveal accelerating output since 2018, with 12 papers in 2022 and continued productivity through 2025. Recent work demonstrates interdisciplinary convergence, particularly in Medical AI (neonatal sepsis, diabetic kidney disease) Natural language processing for low-resource languages Transformer-based architectures across domains Notable patterns include increasing clinical collaborations and emphasis on practical implementation tools. Professional recognition includes an h-index of 13 with 596 citations across 71 research outputs. Key distinctions: Scopus profile verification ORCID registration Multi-institutional collaborations evident in co-authorship Academic supervision and grant activity cannot be confirmed from available data, though 15+ recent publications suggest active research teams. Current projects appear focused on Medical diagnostic tool development Low-resource language technology Clinical decision support systems with evident laboratory infrastructure supporting computational healthcare research.

• Biomedical Engineering
• Cell Engineering
• Biomaterials
• +3 more

Dr. Mathis O. Riehle is a Senior Lecturer in Molecular Biosciences at the University of Glasgow. His research focuses on the molecular mechanisms of cell-surface interactions using micro- and nanofabrication technologies. He is affiliated with the Centre for Cell Engineering and Glasgow Science Centre. Research interests include Biomedical engineering of implantable devices Acoustic manipulation of cells and particles Nanotopography-guided tissue regeneration Biomaterials for nerve and bone repair Microfluidic systems for cell sorting Stem cell microenvironment engineering The 15 most recent publications highlight advancements in acoustic cell sorting, nerve repair scaffolds, and nanoscale mechanotransduction. Key trends involve using surface acoustic waves for particle separation, developing implants for CNS regeneration, and exploring topographical cues for stem cell behavior.

• Heart Valve Disease
• Cardiovascular Magnetic Resonance Imaging
• Aortic Disease
• +5 more

Saul Myerson is an Associate Professor of Cardiovascular Medicine at the University of Oxford, affiliated with St Catherine's College and the Division of Cardiovascular Medicine. He is a Consultant Cardiologist and leads the valve sub-theme at the Oxford Biomedical Research Centre. MB ChB (University of Bristol), MD, FRCP, FESC Principal Investigator for the OxValve Study (>4,000 participants) Board member of the British Society for Cardiovascular Magnetic Resonance His research focuses on heart valve disease , using cardiovascular magnetic resonance (CMR) imaging to identify patients at risk of progression, understand disease mechanisms, and develop treatment strategies. Key areas include: Quantification of valvular regurgitation for surgical planning 4D blood flow imaging to study aortic dilation in bicuspid valves Clinical trials of early valve surgery and novel drugs (e.g., RIAS trial) Community epidemiology of valvular disease (OxValve cohort) Recent publications highlight trends in: Cardiac energetics and metabolic phenotyping in aortic stenosis Flow inefficiencies in non-obstructive hypertrophic cardiomyopathy Sex-specific outcomes and fibrosis prediction models Turner syndrome aortic risk stratification His work is supported by the NIHR Oxford Biomedical Research Centre , British Heart Foundation, and Heart Research UK, with collaborations spanning St Thomas' Hospital , Linkoping University (Sweden), and the International 4D Flow Consortium .

Luke BrewsterView profile

Associate Professor

• Vascular Surgery
• Peripheral Arterial Disease (PAD)
• Biomechanical Mechanisms
• +5 more

Dr. Luke Brewster is an Associate Professor in the Department of Surgery at Emory University School of Medicine , with joint appointments in the Wallace Coulter Department of Biomedical Engineering (Georgia Tech/Emory) and the Atlanta Clinical & Translational Science Institute . As a surgeon-scientist , he investigates biomechanical mechanisms in peripheral vascular disease and develops regenerative strategies for ischemic tissue. Clinical affiliations: Emory University Hospital, Atlanta VA Healthcare System (Section Chief of Vascular Surgery) Research focus: Pathologic vessel remodeling, atherosclerosis, stem cell therapies, and PAD therapeutics Education: MD (Saint Louis University), PhD (Loyola University), MA (Neiswanger Institute), BA (Benedictine College) His laboratory employs animal models and human arterial tissue to quantify biomechanical forces in vascular disease, revealing critical insights for novel therapeutics. Recent work explores exercise therapy , nanotechnology , and stem cell interventions in PAD, with a focus on diabetes and smoking impacts. Dr. Brewster has secured federal, foundation, and industry grants , contributing to over 150 publications. His collaborations bridge bioengineering and clinical vascular surgery , emphasizing interdisciplinary solutions to arterial disease.

• Geriatric Emergency Medicine
• Frailty in Older Adults
• Patient-Reported Outcome Measures
• +3 more

James van Oppen is an NIHR Clinical Lecturer in Emergency Medicine at the University of Sheffield's School of Medicine and Population Health, working a 50/50 clinical-academic split. Based at the Centre for Urgent and Emergency Care Research in Regent Court (ScHARR), he holds a PhD from the University of Leicester (2023) and is a Fellow of the Royal College of Emergency Medicine (FRCEM) and Member of the Royal College of Physicians (MRCP). His educational background includes: PhD in Emergency Medicine, University of Leicester (2023, NIHR Doctoral Research Fellowship) Fellowship of the Royal College of Emergency Medicine (FRCEM) Membership of the Royal College of Physicians (MRCP) Dr. van Oppen specializes in person-centered care for older adults with frailty in emergency settings, with methodological expertise in qualitative research and psychometrics. As chair of the European Society of Emergency Medicine's geriatric emergency medicine section, he leads international collaborations with the European Geriatric Medicine Society, American Geriatrics Society, and other global bodies. His signature achievement is developing the Patient-Reported Outcome Measure for Older People with frailty receiving Acute Care (PROM-OPAC), which earned the 2023 Royal College of Emergency Medicine Rod Little prize. His recent publications reveal three dominant research trajectories: (1) Validation of frailty assessment tools like the Clinical Frailty Scale across European emergency departments, (2) Development and implementation of patient-reported outcome measures specifically for older adults in acute care, and (3) Systems-level analysis of emergency care pathways for frail older people using mixed-methods approaches. These works consistently bridge clinical practice with methodological innovation. His notable recognition includes: Royal College of Emergency Medicine's Rod Little prize (2023) for PROM-OPAC development Dr. van Oppen has supervised undergraduate and Masters students at the University of Leicester and will soon co-supervise a PhD candidate on PROMs research. His work is primarily funded through NIHR mechanisms, including his Doctoral Research Fellowship, and he serves as Chief Investigator for the multinational Frailty in European Emergency Departments (FEED) study. He actively contributes to the Centre for Urgent and Emergency Care Research while leading the European Society of Emergency Medicine's geriatric emergency medicine section, fostering collaborations across 12 countries through the FEED initiative and other international consortia.

Justin MikellView profile

Associate Professor

• Radiation Oncology
• Medical Physics
• Radioembolization
• +4 more

Justin Mikell, PhD is an Associate Professor of Radiation Oncology and Associate Professor of Radiology at Washington University School of Medicine, where he is part of the Division of Medical Physics within the Siteman Cancer Center. He joined Washington University in 2022 after previously holding a faculty position at the University of Michigan, where he was part of the brachytherapy and machine QA teams. Dr. Mikell earned his dual BS degrees in Engineering and Computer Science from the University of Illinois, Urbana-Champaign (2002), followed by a PhD in Medical Physics from the University of Texas at Houston Graduate School of Biomedical Sciences and UT MD Anderson Cancer Center (2015). He completed his residency in Medical Physics at the University of Michigan, Ann Arbor (2018). His research focuses on combination radiotherapy, quantitative emission imaging, and absorbed dose calculations for both microspheres and unsealed sources, particularly Y-90 microspheres. His work has significantly advanced the field of radioembolization for liver cancer treatment, with a special emphasis on precise dosimetry modeling and treatment planning. Dr. Mikell's expertise spans medical physics, radiation oncology, and nuclear medicine, allowing him to bridge these disciplines for improved patient outcomes. Dr. Mikell's publication record demonstrates consistent contributions to the field, with research spanning from technical aspects of dosimetry calculation to clinical applications in liver cancer treatment. His recent work shows increasing focus on integrating advanced imaging techniques like PET/CT with precise dose calculation methods, and exploring combination therapies involving radioembolization and stereotactic body radiation therapy. With approximately 1,200 citations across his 47 research outputs, Dr. Mikell has established himself as a significant contributor to the field of radiation oncology physics, particularly in the area of radioembolization dosimetry and treatment planning. He continues to collaborate extensively with nuclear medicine colleagues and radiation oncologists, advancing research in quantitative imaging for radiation therapy and developing more precise methods for calculating and delivering therapeutic radiation doses to cancer patients.

Matthew HanchardView profile

Research Fellow

• Digital Sociology
• Science and Technology Studies
• Medical Sociology
• +3 more

Dr. Matthew Hanchard is a Research Fellow at the School of Sociological Studies, Politics and International Relations, University of Sheffield, based at the iHuman Institute. He holds Fellowship of the Higher Education Authority (FHEA) status and currently works on the Wellcome Trust-funded project 'Orphan drugs: high prices, access to medicines and the transformation of biopharmaceutical innovation'. His educational background includes: BA in Photography, University of Derby (2006) MA in Photography and Urban Cultures, Goldsmiths, University of London (2008) PhD in Human Geography, Newcastle University (2019) As a digital sociologist and STS scholar , Hanchard investigates social consequences of technology (particularly data flows), cultural consumption patterns , medical sociology , and digital research methodologies . His work bridges sociology, urban studies, and computer science through projects on digital maps, smart city infrastructure, film audiences, and rare disease discourse. Analysis of his 15 most recent publications reveals dominant themes in medical sociology (orphan drugs, rare diseases) and digital cultural consumption (film audiences, platformed media), with strong methodological innovation in computational ontologies and mixed-methods approaches . His research consistently examines power dynamics in technology-society interactions across healthcare, urban environments, and media ecosystems. His recognition includes: Fellow of the Higher Education Authority (FHEA) Hanchard has supervised MA dissertations using digital methods and network theory but is not currently available for primary PhD supervision. His grant portfolio features: Principal Investigator: 'Fostering cultures of open qualitative research' (Research England, £13,914, 2023) Co-Investigator: 'Patient access to orphan drugs' (Research England, £4,575, 2022) Co-Investigator: 'Smart publics' project (Sydney-Glasgow partnership, AU$39,371, 2019-2020) Working Group Member: EU COST action 'Grassroots of Digital Europe' (2022-2026) He actively contributes to the iHuman Institute and multiple research networks including the Global Pharmaceuticals & Society Studies network (GPSS), Open Research Working Group, Social Network Analysis in Scotland (SNAS), and Science Technology and Medicine in Society group (STeMiS).

• Biomedical Engineering
• Cardiovascular Mechanics
• Computational Fluid Dynamics
• +5 more

Fiona Malone is a Lecturer in the Department of Mechanical & Industrial Engineering at the University of Galway, Ireland, where she also serves as a Principal Investigator for both the Engineering Research Group (ERG) and the Medical and Engineering Technologies Gateway (MET). Her research bridges mechanical engineering principles with medical applications, focusing on cardiovascular mechanics and stroke-related phenomena. Dr. Malone's research interests center on the intersection of biomedical engineering and cardiovascular mechanics, with particular emphasis on embolism, atrial fibrillation, and aortic arch hemodynamics. She employs patient-specific modeling approaches to investigate blood flow patterns and emboli trajectory paths under various physiological conditions. Her work combines experimental in vitro studies with computational methods to better understand stroke mechanisms and develop potential interventions. Analysis of Dr. Malone's publications reveals a consistent focus on cardiovascular biomechanics with increasing integration of machine learning techniques in recent years. Her earlier work concentrated on mechanical characterization of embolus analogues and hemodynamics in patient-specific models, while her more recent publications incorporate computational methods like gradient boosting algorithms to address class imbalance problems in medical data analysis. Dr. Malone has achieved significant recognition in her field with an h-index of 78 according to Scopus metrics. Her publications have garnered citations across multiple disciplines, demonstrating the interdisciplinary impact of her research. As a Principal Investigator, Dr. Malone leads research initiatives within the Engineering Research Group and the Medical and Engineering Technologies Gateway. Her collaborative network spans multiple institutions and disciplines, with frequent co-authorship with researchers specializing in both engineering and medical fields. Her research has practical implications for understanding stroke mechanisms and developing improved diagnostic and therapeutic approaches.

OKONGWU UcheView profile

Professor

• Supply Chain Management
• Operations Research
• Decision Support Systems
• +3 more

OKONGWU Uche is a Professor at the Toulouse Business School within the Department of Information, Operations and Decision Sciences . His academic work focuses on the intersection of supply chain management, decision science, and operational optimization, with a particular emphasis on sustainability and responsiveness in complex systems. Supply Chain Management Operations Research Decision Support Systems Humanitarian Logistics Genetic Algorithms Order Fulfillment His research explores advanced methodologies like heuristic-based genetic algorithms for multi-project scheduling, robust humanitarian facility location models, and sustainable supply chain planning frameworks. He has contributed to empirical studies on how supply chain practices impact organizational performance and tactical planning determinants. Recent publications highlight trends in humanitarian logistics , emergency response systems , and supply chain sustainability . His work includes tools for optimizing order fulfillment in stock-out situations and improving the maturity of sustainability disclosures in supply chains. For detailed publications, refer to the articles section. Contact: u.okongwu@tbs-education.fr .

Olachi Mezu-NdubuisiView profile

Associate Professor

• Retinopathy of Prematurity (ROP)
• Translational Research
• Global Health Disparities
• +7 more

Olachi Mezu-Ndubuisi is an Associate Professor at the University of Rochester School of Medicine and Dentistry , holding joint appointments in Department of Pediatrics, Neonatology and Department of Ophthalmology . She leads the Mezu-Ndubuisi Lab at the Flaum Eye Institute and McPherson Eye Research Institute , focusing on Retinopathy of Prematurity (ROP) and global health disparities . Her research centers on translational studies of ROP pathogenesis using in vivo mouse models with advanced imaging techniques like phosphorescence lifetime imaging and fluorescein angiography . Key projects include: Investigating VEGF-A microparticles and topical calcitriol for ROP therapy Developing non-invasive retinal imaging methodologies Exploring oxidative stress effects on multiple organ systems in preterm infants Recent publications (2016-2022) span: Retinal vascular imaging (Brain Research, Investigative Ophthalmology & Visual Science) Ocular angiogenesis (Pediatric Research, Current Eye Research) Global health interventions (Annals of Global Health, International Journal of Pediatrics) Scientific recognition includes: Edwin and Dorothy Gamewell Professor (2021-2024) K08 Career Development Award (2021-2026) Young Investigator Awards (2012, 2017) Fellow of American Academy of Optometry (2017) As academic mentor, she: Guides 14+ students/interns across disciplines Directs Mezu International Foundation medical missions in Nigeria Leads global health research initiatives with community partners Lab activities feature: Annual global health missions serving 1300+ patients Collaborations with Nigerian universities (Abia State University, Federal University of Technology Owerri) Training undergraduate researchers in clinical and translational methods

• Biomechanics
• Cardiovascular system
• Computational modeling
• +7 more

Claudio Chiastra is an Associate Professor at the Department of Mechanical and Aerospace Engineering (DIMEAS) at the Polytechnic of Turin, where he is also a member of the Interdepartmental Center PolitoBIOMed Lab - Biomedical Engineering Lab. His academic career spans multiple institutions including the Polytechnic University of Milan and Erasmus Medical Center, demonstrating his expertise in cardiovascular biomechanics and medical device development. Dr. Chiastra's research focuses on biomechanics, cardiovascular system modeling, computational approaches to coronary artery disease, digital twin technology, endovascular device design, and multiscale modeling of vascular systems. His work integrates optical coherence tomography with stent technology to advance cardiovascular interventions. His research lines include multiscale modeling of vascular adaptation processes, design and optimization of endovascular devices, 3D reconstruction of vascular geometries through multimodal imaging integration, and studying relationships between morphometric, mechanical and hemodynamic descriptors in vascular diseases. His recent publications reveal a strong emphasis on computational modeling of coronary interventions, stent design optimization, plaque analysis, and hemodynamic assessment. These works demonstrate his leadership in applying advanced computational techniques to solve clinical cardiovascular challenges, particularly in coronary artery disease treatment and prevention. GNB (National Bioengineering Group) Doctoral Award (2014) Dr. Chiastra actively mentors PhD students including Francesca Rossi, Mariachiara Arminio, Graziana Maria Ragonese, and Sara Zambon. He leads significant research projects including RESET (REthinking femoral artery Stents) and PREDICT (Adverse cardiovascular events in coronary Plaques), demonstrating his leadership in securing competitive research funding. His editorial roles as Associate Editor for Frontiers in Medical Technology, Frontiers in Cardiovascular Medicine, and Scientific Reports highlight his recognition in the field. As a member of the PolitoBIOMed Lab, Dr. Chiastra contributes to a collaborative research environment focused on biomedical engineering solutions. His work bridges engineering principles with clinical cardiovascular applications, particularly in the development and optimization of endovascular devices and computational models for personalized medicine approaches.